Edwards Lifesciences continues to enjoy huge success with TAVR, while St. Jude Medical and Boston Scientific scramble to get MRI compatible pacemakers and defibrillators on the market to stay competitive.
Those are but some of the highlights from the recent slew of earnings news from major medical device companies. Here are some of the highlights:
Edwards Lifesciences: Strong Demand for TAVR
Edwards Lifesciences ended 2015 with annual sales of about $2.5 billion, with an underlying growth rate of 17% that exceeded expectations. The news on February 2 helped Edwards stock shoot up about 8% in a single day, and it is still trading at more than $80 per share, after hitting an all-time high of $84.36 on February 4.
